JSKN016 Clinical Trials
2 recruitingDrug
Phase 12Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 1
Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
Advanced Non-Small Cell Lung Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd288 enrolled1 locationNCT06868732
Recruiting
Phase 1Phase 2
Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer
Inoperable Locally Advanced HER2-Negative Breast CancerMetastatic HER2-Negative Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd180 enrolled1 locationNCT06942234